Why Lang & Pattisson are shorting Glaxo, SABMiller and Drax

The Jeremy Lang and Bill Pattisson-managed Ardevora UK Equity fund has a number of contrarian positions and they explain the rationale behind three of their top shorts.

Back to article

You must be signed in to use the email a friend service. Click here to sign in or register

Sorry, this link is not
quite ready yet